title: Endpoints in preclinical Alzheimer's disease trials.
authors.affiliation: Banner Alzheimer's Institute, 901 E Willetta St, Phoenix, AZ 85006 eric.reiman@bannerhealth.com.
authors.forename: Eric M
authors.initials: EM
authors.lastname: Reiman
authors.forename: Jessica B
authors.initials: JB
authors.lastname: Langbaum
authors.forename: Pierre N
authors.initials: PN
authors.lastname: Tariot
mesh_terms: D000483:Alleles; D000544:Alzheimer Disease / Q000235:genetics* / Q000517:prevention & control*; D002869:Chromosome Aberrations; D004252:DNA Mutational Analysis; D005799:Genes, Dominant / Q000235:genetics*; D006580:Genetic Carrier Screening; D006801:Humans; D009483:Neuropsychological Tests / Q000706:statistics & numerical data*; D053764:Presenilin-1 / Q000235:genetics*
chemical_list: C508853:PSEN1 protein, human; D053764:Presenilin-1